Optically-based stimulation of target cells and modifications thereto

Patent metadata

Field	Value
Publication number	US-10071132-B2
Application number	US-201615095519-A
Country	US
Kind code	B2
Filing date	Apr 11, 2016
Priority date	Nov 14, 2008
Publication date	Sep 11, 2018
Grant date	Sep 11, 2018

Abstract

Stimulation of target cells using light, e.g., in vivo or in vitro, is implemented using a variety of methods and devices. One example involves a vector for delivering a light-activated molecule comprising a nucleic acid sequence that codes for light-activated molecule. The light-activated molecule includes a modification to a location near the all-trans retinal Schiff base, e.g., to extends the duration time of the open state. Other aspects and embodiments are directed to systems, methods, kits, compositions of matter and molecules for ion channels or pumps or for controlling currents in a cell (e.g., in in vivo and in vitro environments).

First claim

What is claimed is:

1. A method of modulating the activity of a mammalian neuron, the method comprising exposing the mammalian neuron to blue light, wherein the mammalian neuron is genetically modified to comprise a heterologous nucleic acid comprising a nucleotide sequence encoding a light-responsive ion channel comprising an amino acid sequence having at least 90% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1, wherein the ion channel exhibits an extended conducting state after exposure to a light pulse, and wherein the ion channel comprises a substitution of a Cys residue at a position corresponding to amino acid residue 128 (C128) of SEQ ID NO:1 with a serine and a substitution of an Asp residue at a position corresponding to amino acid residue 156 (D156) of SEQ ID NO:1 with an alanine, wherein the light-responsive ion channel is expressed in the mammalian neuron, and wherein said exposing depolarizes the mammalian neuron, thereby activating the neuron.

2. The method of claim 1 , wherein the light-responsive ion channel comprises a substitution of a Glu residue at a position corresponding to amino acid 123 of SEQ ID NO:1.

3. The method of claim 1 , wherein the light-responsive ion channel comprises a substitution of a His residue at a position corresponding to amino acid 134 of SEQ ID NO:1.

4. The method of claim 1 , wherein the light-responsive ion channel comprises an amino acid sequence having at least 95% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1.

5. The method of claim 1 , wherein the mammalian neuron is in vivo.

6. The method of claim 1 , wherein the mammalian neuron expresses a hyperpolarizing light-activated chloride pump, wherein exposing the hyperpolarizing light-activated chloride pump to yellow light hyperpolarizes the mammalian neuron, thereby inhibiting the neuron.

7. The method of claim 6 , wherein the hyperpolarizing light-activated chloride pump comprises an amino acid sequence having at least 90% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:3.

8. The method of claim 1 , wherein the mammalian neuron is a hippocampal neuron.

9. The method of claim 1 , wherein the mammalian neuron is a cholinergic motoneuron.

10. The method of claim 1 , wherein the mammalian neuron is a GABAergic neuron.

Assignees

• Univ Leland Stanford Junior

Inventors

• Deisseroth Karl
• Yizhar Ofer
• Gunaydin Lisa
• Hegemann Peter
• Berndt Andre

Classifications

• A61P25/00

  Drugs for disorders of the nervous system · CPC title

• C07K14/405

  from algae · CPC title

• A61K38/16 Primary

  Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof {(enzyme inhibitors A61K38/005)} · CPC title

• C12N13/00

  Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title

• A61N5/0622

  Optical stimulation for exciting neural tissue · CPC title